Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.765 USD | +2.04% | +20.57% | +70.66% |
03-19 | North American Morning Briefing : Stock Futures -2- | DJ |
03-14 | Larimar Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 42
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | - | |
Michael Celano
DFI | Director of Finance/CFO | 65 | 27/05/20 |
Noreen Scherer
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/18 |
John Berman
ADM | Chief Administrative Officer | 57 | 31/12/16 |
Compliance Officer | - | 30/11/16 | |
Russell Clayton
CTO | Chief Tech/Sci/R&D Officer | - | 16/07/23 |
Gopi Shankar
PRN | Corporate Officer/Principal | - | 06/02/23 |
Comptroller/Controller/Auditor | - | 30/06/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Leff
BRD | Director/Board Member | 55 | 27/05/20 |
Frank Thomas
BRD | Director/Board Member | 54 | 27/05/20 |
Jeffrey Sherman
BRD | Director/Board Member | 69 | 02/10/23 |
Chief Executive Officer | 65 | - | |
Joseph Truitt
CHM | Chairman | 59 | 27/05/20 |
Thomas Hamilton
BRD | Director/Board Member | 56 | 27/05/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,800,017 | 62,874,711 ( 98.55 %) | 0 | 98.55 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.66% | 495M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- LRMR Stock
- Company Larimar Therapeutics, Inc.